PGNY News and Press, Progyny Inc. From 01/20/21

Progyny (NASDAQ: PGNY) is a recent healthcare IPO that aims to revolutionize the fertility industry. And with a market cap of just over $4 billion, it could still have a long way to grow in a huge market that's just begging to be disrupted. In this Jan. 7 Fool Live clip, Fool.co...

NEW YORK, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will present...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week aheadThe week ahead will see investors once again weigh the brightening prospects for COVID-19 vaccines against a surging pand...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...

NEW YORK, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions in the United States, today announced that David Schlanger, Progyny’s Chief Executive Officer, will partici...

Progyny, Inc. (PGNY) Q3 2020 Earnings Conference Call November 5, 2020 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations David Schlanger - Chief Executive Officer Pete Anevski - Chief Operating Officer Mark Livingston - Chief Financial Officer Conference Call P...

Progyny went public in October 2019, raising $130 million. The firm provides fertility and family planning benefit services in the United States. PGNY has grown remarkably and begun to turn a profit, but will need to ramp up profits to justify its current stock price, so I'm Neutr...

Progyny (PGNY): Q3 GAAP EPS of $0.05 beats by $0.01.Revenue of $98.9M (+61.6% Y/Y) beats by $6.36M.Q4 guidance: Revenue of $95.4M-$100.4M, reflecting growth of 47% to 54% vs consensus of $99.5M ; Net income of $5.1M-$6.6 M, income/share of $0.05-$0.07; Adjusted EBITDA of $9.0M-$10.3M.FY2...

Reports Record Third Quarter Revenue of $98.9 Million Raises Revenue Guidance to $340.0 to $345.0 Million for Full Year 2020, Reflecting Growth of 48% to 50% Affirms Preliminary View of a Minimum of $525 Million in 2021 Revenue NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Progyny, In...

[[AAXN]], [[ACLS]], [[ADT]], [[AGO]], [[AIG]], [[AINV]], [[ALRM]], [[ALTR]], [[AMCR]], [[AMH]], [[AMN]], [[ANGI]], [[APPN]], [[ATGE]], [[ATRC]], [[AVLR]], [[AYX]], [[AZPN]], [[BFAM]], [[BGS]], [[BHF]], [[BIGC]], [[BILL]], [[BKNG]], [[BLDP]], [[BMRN]], [[BNFT]], [[CABO]], [[CARG]], [[CDAY]], [...